JP Stock MarketDetailed Quotes

4892 Cyfuse Biomedical KK

Watchlist
  • 440
  • -12-2.65%
20min DelayTrading Dec 23 14:45 JST
3.58BMarket Cap-5.83P/E (Static)

Cyfuse Biomedical KK Key Stats

EPS
According to the latest financial report of Cyfuse Biomedical KK, the latest earnings per share (TTM) for the company is -27.77. Investing in companies with strong earnings per share can potentially provide higher returns.

Currency: JPY

Quarterly

Loading...

FCF
Interested in knowing about Cyfuse Biomedical KK's free cash flow? The latest report shows it as --. Keep an eye on and closely monitor the company's cash flow to make informed investment decisions.

Currency: JPY

Quarterly

Loading...

Current Ratio
If you are evaluating a company's liquidity, current ratio is an important measure to consider. The latest financial report of Cyfuse Biomedical KK shows that the company's current ratio is 6.11, indicating healthy liquidity.

Currency: JPY

Quarterly

Loading...

Quick Ratio
Another liquidity indicator to closely monitor is quick ratio. According to the latest financial results of Cyfuse Biomedical KK, the quick ratio is 5.91, indicating that the company can meet its short-term debt obligations.

Currency: JPY

Quarterly

Loading...

ROE
Want to learn more about the financial health of Cyfuse Biomedical KK? The latest ROE figure is -7.52%, indicating that the company has stable profitability.

Currency: JPY

Quarterly

Loading...

ROA
Investors looking for profitability indicators may be interested in ROA. According to the latest financial results of Cyfuse Biomedical KK, the total asset return on investment (ROA) is -5.75%.

Currency: JPY

Quarterly

Loading...

Gross Margin
Gross margin can provide insight into a company's pricing strategy and cost structure. Check Cyfuse Biomedical KK's latest financial report to see how their gross margin is doing - currently at 15.25%.

Currency: JPY

Quarterly

Loading...

Net Margin
For investors focusing on operational efficiency, net profit margin is an important indicator. According to the latest financial results of Cyfuse Biomedical KK, the net profit margin is -3.06K%, which is a good sign for its profitability.

Currency: JPY

Quarterly

Loading...